Saturday 31 October 2026
Export DOC’s income statement to Excel — free account
Healthpeak Properties, Inc.
DOC Real Estate Reit Healthcare Facilities
Healthpeak Properties, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.8 billion, up 4.52% from fiscal 2024. In the quarter to June 2026, revenue grew 11.1%, EPS grew 60.0%, free cash flow fell 30.5% and total debt rose 11.0%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for five consecutive years, operating cash flow growth for five.
19.03
0.09
+0.48%
Follow DOC
Alert me
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 160.80 | 51.34 | 61.14 |
P/S ratio |
4.75 | 3.97 | 3.98 | 5.00 | |
P/FCF ratio |
26.12 | 32.98 | 255.36 | 0.00 | |
P/Operating CF |
42.25 | 38.06 | 43.78 | 40.88 | |
P/B ratio |
1.62 | 1.37 | 1.26 | 1.56 | |
Price to Tangible BV |
1.74 | 1.51 | 1.39 | 1.70 | |
EV/Sales |
7.95 | 7.26 | 7.16 | 7.82 | |
EV/EBITDA |
15.32 | 13.90 | 14.13 | 15.57 | |
EV/Operating CF |
17.95 | 16.38 | 16.68 | 18.75 | |
EV/FCF |
43.74 | 60.42 | 460.09 | (1,193.91) | |
Quick Ratio |
0.32 | 0.86 | 2.02 | 2.64 | |
Current Ratio |
1.22 | 1.70 | 2.96 | 3.02 | |
Net Debt/EBITDA |
24.42 | 24.89 | 25.64 | 21.70 | |
Debt/Assets |
46.63% | 48.43% | 48.22% | 46.27% | |
Debt/Equity |
1.11 | 1.21 | 1.15 | 1.06 | |
Asset Turnover |
0.14 | 0.14 | 0.14 | 0.14 | |
Operating CF/Net income |
(2.69) | 2.58 | 1.35 | 6.86 | |
Capex/Depreciation |
(0.85) | (1.50) | (1.81) | (0.83) | |
Interest Coverage |
1.68 | 1.73 | 1.06 | 1.35 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
2.82% | 3.28% | 3.27% | 2.92% | |
Intangible Assets out of Total Assets |
0.03 | 0.04 | 0.04 | 0.04 | |
Share Based Compensation of Revenue |
0.57% | 0.56% | 1.24% | 0.62% | |
Graham Net Nets |
(0.78) | (0.98) | (0.93) | (0.69) | |
Graham Number |
0.00 | 5.13 | 9.67 | 10.40 | |
Earnings Yield |
(0.26%) | 0.62% | 1.95% | 1.64% | |
Free Cash Flow Yield |
3.83% | 3.03% | 0.39% | (0.13%) | |
Revenue per Share |
1.02 | 1.03 | 1.08 | 1.12 | |
Operating CF per Share |
0.45 | 0.42 | 0.38 | 0.52 | |
Capex per Share |
(0.29) | (0.51) | (0.69) | (0.31) | |
Free Cash Flow per Share |
0.16 | (0.08) | (0.31) | 0.21 | |
Cash per Share |
0.23 | 0.77 | 1.82 | 2.49 | |
Shareholders Equity per Share |
11.85 | 11.70 | 12.99 | 13.73 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
11.85 | 11.70 | 12.99 | 13.73 | |
Free Cash Flow |
111.65 | (58.42) | (218.74) | 146.19 | |
Working Capital |
167.85 | 503.54 | 1,317.78 | 1,373.53 | |
Capital Expenditures |
(203.31) | (352.51) | (479.62) | (214.91) | |
Net Current Asset Value |
(10,430.83) | (10,971.10) | (10,594.41) | (10,157.08) | |
EV/EBIT |
46.36 | 39.47 | 42.94 | 47.45 | |
Capex to Sales |
0.29 | 0.49 | 0.64 | 0.28 | |
Price to Operating Income |
27.69 | 21.54 | 23.83 | 30.35 | |
| Other line items | |||||
Average Receivables |
72.91 | 77.57 | 80.19 | 70.44 | |
Average Payables |
748.06 | 721.93 | 670.73 | 708.65 | |
Average Assets |
19,776.09 | 20,137.14 | 20,715.98 | 20,745.16 | |
Average Common Equity |
8,729.09 | 8,598.94 | 8,930.90 | 9,018.79 |
Columns are period end dates